Screener
Allarity Therapeutics, Inc. ALLR Q1 2026 earnings
Reported May 15, 2026 · Before market open
Revenue$25.0KIn line
EPS-$0.17Beat by $0.05
Revenue estimate$25.0K
EPS estimate-$0.22
Next report
Nov 13, 2026 (in 2 months)EPS estimate-$0.25
Versus estimates
Revenue
Q1 2026$25.0KIn line
Q4 2025$320.0KIn lineDiluted EPS
FAQ
- When did Allarity Therapeutics, Inc. report Q1 2026 earnings?
- Allarity Therapeutics, Inc. (ALLR) reported Q1 2026 earnings on May 15, 2026 before market open.
- What were Allarity Therapeutics, Inc.'s Q1 2026 revenue and EPS?
- Allarity Therapeutics, Inc. reported revenue of $25.0K and eps of $-0.17 for Q1 2026.
- Did Allarity Therapeutics, Inc. beat estimates in Q1 2026?
- Revenue beat the consensus estimate of $25.0K by -. EPS beat the consensus estimate of $-0.22 by $0.05.
- How did Allarity Therapeutics, Inc.'s Q1 2026 results compare year-over-year?
- Compared to the same quarter a year prior, eps grew 32.0% from $-0.25.
- Where can I find Allarity Therapeutics, Inc.'s Q1 2026 SEC filings?
- You can read the 10-Q periodic report (0001437749-26-017371) directly on SEC EDGAR. The filing index links above go to sec.gov.
